Sanofi | SNY - Current Assets



Sanofi reported 37.02B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
AbbVie USD 27.68B 2.09B Mar/2025
Amgen USD 26.73B 195M Jun/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Canopy Growth CAD 303.36M 37.72M Jun/2025
Corcept Therapeutics USD 443.11M 4.61M Jun/2025
Drreddys Laboratories INR 269.9B 16.88B Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
Galapagos EUR 3.26B 217.04M Jun/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Glaxosmithkline GBP 17.67B 676M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Merck USD 37.07B 1.56B Jun/2025
Novartis USD 25.94B 831M Jun/2025
Novartis USD 25.94B 3.76B Jun/2025
Pacira USD 745.61M 14.35M Jun/2025
Perrigo USD 2.62B 82M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Prestige Brands USD 480.52M 32.19M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025
Sanofi 37.02B 5.57B Jun/2025
Supernus Pharmaceuticals USD 738.87M 51.28M Jun/2025
UCB EUR 4.79B 1.47B Dec/2024
Zoetis USD 5.92B 46M Jun/2025